Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,275 | N/A | N/A | N/A | 12 |
| Marketable Securities | N/A | 20 | 302 | 391 | 525 |
| TOTAL | $1,912 | $39 | $374 | $515 | $651 |
| Non-Current Assets | |||||
| PPE Net | 115 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 15 | 73,516 | 73,515 | 73,513 | 73,511 |
| TOTAL | $130 | $73,516 | $73,515 | $73,513 | $73,511 |
| Total Assets | $2,042 | $73,556 | $73,888 | $74,028 | $74,162 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 596 | 1,594 | 1,084 | 384 | 34 |
| Accrued Expenses | 1,529 | N/A | N/A | N/A | N/A |
| Other current liabilities | N/A | 2,143 | 2,229 | 1,738 | 3,400 |
| TOTAL | $2,142 | $3,738 | $3,313 | $2,121 | $3,434 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 73,509 | 73,509 | 73,509 | 73,509 |
| TOTAL | $N/A | $76,421 | $76,421 | $76,421 | $76,421 |
| Total Liabilities | $2,142 | $80,158 | $79,733 | $78,542 | $79,854 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,083 | 9,098 | 7,992 | 7,952 | 9,098 |
| Common Shares | 0 | 2 | 2 | 2 | 2 |
| Retained earnings | -14,517 | -6,604 | -5,847 | -4,516 | -5,694 |
| TOTAL | $-100 | $-6,603 | $-5,845 | $-4,514 | $-5,692 |
| Total Liabilities And Equity | $2,042 | $73,556 | $73,888 | $74,028 | $74,162 |